It appears no script is enabled within your browser. Please enable JavaScript to use this site.
Skip header and navigation
COVID-19 Rapid Evidence Reviews
Toggle navigation
New Search
SK Repository
About
Help
Your Cart:
0
items
Refine Search
Refine Search
Revise search
Search
Document Type
Apply
Evidence Search Report
2
Rapid Review
2
Table
2
Research Team
Apply
EOC
Epidemiology & Modelling
3
Status
Apply
5. Updated review
3
3. Completed
3
Category
Apply
Clinical Management
3
Clinical Presentation
3
Healthcare Services
3
Subject
Apply
Acute Care
1
Aerosols
7
Antigens
4
Asymptomatic
3
Cancer
3
Chemotherapy
3
Clinical Presentation
10
Closures
3
Comorbidities
Critical Care
5
Decision Making
28
Disease Outbreak
2
More
Population
Apply
All
Other
3
vulnerable populations (clinically)
3
Clinical Setting
Apply
Cardiac unit
3
Community
3
Dialysis unit
3
ICU
3
Long Term Care
3
Medicine Unit
3
NICU
3
Oncology
3
Primary care
3
Public Health
3
Advanced Search
All Records
All
EOC
Comorbidities
Sorted by
Oldest
Sort by Relevance
Sort by Research Question / Title
Sort by Newest
Table View
List View
Citation View
Expand all
Collapse all
Select All
6 records – page 1 of 1.
Prev
Next
Date
Research Question / Title
Unique ID
Research Team
January 4, 2021
What are the differences in the clinical course of COVID-19 between patients undergoing chemotherapy and otherwise healthy individuals? [Update]
EOC062201v2-01 ESR
EOC
January 22, 2021
What are the differences in the clinical course of COVID-19 between patients undergoing chemotherapy and otherwise healthy individuals? [Update]
EOC062201v2 RR
EOC
January 22, 2021
What are the differences in the clinical course of COVID-19 between patients undergoing chemotherapy and otherwise healthy individuals? [Update]
EOC062201v2 RR Table
EOC
April 1, 2021
What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations?
EOC210302 ESR
EOC
April 21, 2021
What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations?
EOC210302 RR
EOC
April 21, 2021
What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations?
EOC210302 RR Table
EOC
6 records – page 1 of 1.
Prev
Next